MEPOLIZUMAB (Nucala®)
Clinical Indication
To treat severe eosinophilic asthma.
Comments
In line with NICE TA 431
Date of classification
June 2018
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.